ezetimibe has been researched along with thyroxine in 8 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (thyroxine) | Trials (thyroxine) | Recent Studies (post-2010) (thyroxine) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 38,989 | 1,410 | 6,550 |
| Protein | Taxonomy | ezetimibe (IC50) | thyroxine (IC50) |
|---|---|---|---|
| Transthyretin | Homo sapiens (human) | 2.1939 | |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | 5.25 | |
| Solute carrier organic anion transporter family member 4C1 | Homo sapiens (human) | 8 | |
| Bile acid receptor | Homo sapiens (human) | 7.86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carlson, HE; John-Kalarickal, J; Pearlman, G | 1 |
| Angelin, B; Bonde, Y; Gälman, C; Matasconi, M; Rudling, M | 1 |
| Ananthakrishnan, S; Braverman, LE; Levin, RM; Magnani, B; Pearce, EN | 1 |
| Abbott, L; Farah, R; Gopaluni, S; Hutchison, R; Perzova, R; Poiesz, BJ; Shrimpton, A | 1 |
| DeBarber, AE; Jones, PJH; Mymin, D; Myrie, SB; Othman, RA; Roullet, JB; Steiner, RD | 1 |
2 review(s) available for ezetimibe and thyroxine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
CD8+ cutaneous T-cell lymphoma successfully treated with bexarotene: a case report and review of the literature.
Topics: Antineoplastic Agents; Azetidines; Bexarotene; Carcinoma, Renal Cell; CD8-Positive T-Lymphocytes; Contraindications; Exanthema; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Hypothyroidism; Incidental Findings; Kidney Neoplasms; Male; Middle Aged; Mycosis Fungoides; Neoplasms, Multiple Primary; Simvastatin; Skin Neoplasms; Tetrahydronaphthalenes; Thyroxine | 2008 |
3 trial(s) available for ezetimibe and thyroxine
| Article | Year |
|---|---|
New medications which decrease levothyroxine absorption.
Topics: Adult; Anticholesteremic Agents; Azetidines; Chelating Agents; Drug Interactions; Ezetimibe; Female; Humans; Hypercholesterolemia; Hypothyroidism; Intestinal Absorption; Iron Chelating Agents; Male; Picolinic Acids; Polyamines; Sevelamer; Thyroxine | 2007 |
The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption.
Topics: Adult; Anti-Ulcer Agents; Anticholesteremic Agents; Azetidines; Dose-Response Relationship, Drug; Esomeprazole; Ezetimibe; Famotidine; Female; Humans; Intestinal Absorption; Male; Random Allocation; Thyroxine; Triiodothyronine | 2008 |
Thyroid Hormone Status in Sitosterolemia Is Modified by Ezetimibe.
Topics: Adolescent; Adult; Anticholesteremic Agents; Cholestanol; Cholestenones; Cholesterol; Ezetimibe; Female; Humans; Hypercholesterolemia; Intestinal Diseases; Lipid Metabolism, Inborn Errors; Male; Middle Aged; Phytosterols; Sitosterols; Thyrotropin; Thyroxine; Triiodothyronine; Young Adult | 2017 |
3 other study(ies) available for ezetimibe and thyroxine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Dramatically increased intestinal absorption of cholesterol following hypophysectomy is normalized by thyroid hormone.
Topics: Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; ATP-Binding Cassette Transporters; Azetidines; Cholesterol; Cholesterol, Dietary; Cortisone; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 7; Disease Models, Animal; Drug Therapy, Combination; Ezetimibe; Follow-Up Studies; Gas Chromatography-Mass Spectrometry; Gene Expression; Hypercholesterolemia; Hypophysectomy; Hypopituitarism; Injections, Subcutaneous; Intestinal Absorption; Lipoproteins; Liver; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Steroid Hydroxylases; Thyroxine; Treatment Outcome | 2008 |